Correlation Between Purple Biotech and Aptevo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Aptevo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Aptevo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Aptevo Therapeutics, you can compare the effects of market volatilities on Purple Biotech and Aptevo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Aptevo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Aptevo Therapeutics.
Diversification Opportunities for Purple Biotech and Aptevo Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Purple and Aptevo is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Aptevo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptevo Therapeutics and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Aptevo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptevo Therapeutics has no effect on the direction of Purple Biotech i.e., Purple Biotech and Aptevo Therapeutics go up and down completely randomly.
Pair Corralation between Purple Biotech and Aptevo Therapeutics
Given the investment horizon of 90 days Purple Biotech is expected to under-perform the Aptevo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Purple Biotech is 1.78 times less risky than Aptevo Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Aptevo Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 79.00 in Aptevo Therapeutics on August 31, 2024 and sell it today you would lose (50.50) from holding Aptevo Therapeutics or give up 63.92% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 99.21% |
Values | Daily Returns |
Purple Biotech vs. Aptevo Therapeutics
Performance |
Timeline |
Purple Biotech |
Aptevo Therapeutics |
Purple Biotech and Aptevo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Purple Biotech and Aptevo Therapeutics
The main advantage of trading using opposite Purple Biotech and Aptevo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Aptevo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptevo Therapeutics will offset losses from the drop in Aptevo Therapeutics' long position.Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Aptevo Therapeutics vs. Kronos Bio | Aptevo Therapeutics vs. Cyclerion Therapeutics | Aptevo Therapeutics vs. Larimar Therapeutics | Aptevo Therapeutics vs. Addex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |